Your session is about to expire
← Back to Search
Remote Exercise Program for Chronic Respiratory Diseases
N/A
Waitlist Available
Led By Diana C Sanchez-Ramirez, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial evaluates using technology to remotely exercise and assess health outcomes for patients with chronic lung diseases. Outcomes will measure lung function, fatigue, exercise capacity, self-efficacy, and quality of life. Video calls & smart watches will be used.
Who is the study for?
This trial is for people in Manitoba with chronic lung diseases like COPD or ILD. Participants need to have a confirmed diagnosis, access to a smartphone or tablet, and home internet service.Check my eligibility
What is being tested?
The study tests if a remote exercise program can help patients with chronic lung diseases. It uses video calls and smartwatches to monitor health outcomes like lung function, breathlessness, fatigue, exercise capacity, confidence in managing their condition, and overall quality of life.See study design
What are the potential side effects?
Since the intervention involves an at-home exercise program delivered virtually without medications or invasive procedures, significant side effects are not expected. However, participants may experience general discomfort from physical activity.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Dyspnea
Change in Dyspnea severity
Change in Exercise Capacity
+6 moreSecondary outcome measures
Participant feedback questionnaire
Trial Design
1Treatment groups
Experimental Treatment
Group I: Small group zoom meetingExperimental Treatment1 Intervention
2 groups of 6 participants will be asked to follow the exercise program with their peers in a zoom meeting 3 times a week for 45 min each time. This time includes 5 min before and 10 min after for free talk and chat between participants. There will also be a weekly zoom education session for 30min.
Find a Location
Who is running the clinical trial?
Manitoba Medical Service FoundationOTHER
18 Previous Clinical Trials
1,042 Total Patients Enrolled
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,498 Total Patients Enrolled
Diana C Sanchez-Ramirez, PhDPrincipal InvestigatorUniversity of Manitoba
1 Previous Clinical Trials
14 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My condition has recently worsened.I have a history of neurological disease or mental illness.I need help to walk and cannot do it alone.I have been diagnosed with COPD or ILD.
Research Study Groups:
This trial has the following groups:- Group 1: Small group zoom meeting
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still opportunity to join the experiment?
"According to information available on clinicaltrials.gov, this particular medical trial is no longer actively seeking participants; the study was initially made public on May 1st 2023 and last edited April 10th of the same year. However, at present time there are 501 other studies looking for patients."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger